Global News

Array BioPharma names Michael Needle as chief medical officer

Friday, March 22, 2013 11:14 AM

Array BioPharma, a biopharmaceutical company focused on targeted small molecule drugs to treat cancer, has appointed Michael N. Needle, M.D., as its chief medical officer. 

More... »

AstraZeneca, Moderna Therapeutics to develop pioneering messenger RNA Therapeutics

Friday, March 22, 2013 10:51 AM

AstraZeneca, a global biopharmaceutical company, has formed an exclusive agreement with Moderna Therapeutics, a Cambridge-Mass.-based biopharmaceutical company, to discover, develop and commercialize pioneering messenger RNA therapeutics for the treatment of serious cardiovascular, metabolic and renal diseases as well as cancer.

More... »

Adocia announces its phase III program of BioChaperone for diabetic foot ulcer

Wednesday, March 20, 2013 01:26 PM

Adocia, a biotechnology company specializing in medicines from already approved therapeutic proteins, has announced the phase III development program of its product, BioChaperone PDGF-BB for the treatment of diabetic foot ulcer (DFU). The European Medicines Agency issued positive scientific advice for this program.

More... »

Almac to host clinical trial workshop series

Wednesday, March 20, 2013 11:06 AM

The Almac Group is hosting its third international series of complimentary workshops this spring, titled “Protocol to Patient: Managing Clinical Supplies in an Evolving Marketplace.”

More... »

Malaysian Bio-XCell, Agila Biotech ink $34M Build-and-Lease Agreement

Wednesday, March 20, 2013 10:37 AM

Malaysian Bio-XCell and Agila Biotech signed a $34.4 million Build-and-Lease Agreement for the establishment of a customized biotech facility located in the Bio-XCell biotechnology park and ecosystem in Nusajaya, Malaysia.

More... »

Wilex, Nuclea Biotechnologies form partnership

Wednesday, March 20, 2013 10:08 AM

Pittsfield, Mass-based biomarker pioneer Nuclea Biotechnologies has formed a new long-term partnership with biopharmaceutical company Wilex, which could lead to more effective treatment management for women with metastatic breast cancer. The partnership aims to advance R&D of biomarkers, a vital component in the growing field of personalized medicine. 

More... »

Scripps Research, Takeda expand research collaboration

Wednesday, March 20, 2013 09:11 AM

The Scripps Research Institute (TSRI), an independent, not-for-profit organization focusing on research in the biomedical sciences, and Takeda Pharmaceutical, a research-based global pharmaceutical company, plan to expand their recent research collaboration to search for new drug targets for a variety of diseases.

More... »

U.K.’s Technology Strategy Board and Indian government sign program of co-operation

Tuesday, March 19, 2013 11:30 AM

The Technology Strategy Board (TSB) and the Indian government’s Department of Science and Technology have agreed to undertake a joint program to support innovative U.K. and Indian businesses working together on the commercialization of research in a range of key areas, including energy and healthcare. The ‘Program of Co-operation’ was signed at an international reception held at the InnovateUK conference in London.

More... »

INC Research appoints James Taylor as vice president of clinical development

Tuesday, March 19, 2013 08:00 AM

INC Research, a therapeutically focused global CRO, has appointed James Taylor as vice president of clinical development.

More... »

AstraZeneca to establish strategic R&D centers, cut or relocate 4,100 workers

Monday, March 18, 2013 02:12 PM

Global biopharmaceutical company AstraZeneca announced plans to invest in strategic R&D centers in the U.K., the U.S. and Sweden to improve pipeline productivity and to establish the company as a global leader in biopharmaceutical innovation.

More... »